 | • レポートコード：MRC2Q12-18943 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、シドホビルの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にシドホビルのグローバル市場のxxx％を占める「溶液」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「サイトメガロウイルス網膜炎治療」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 シドホビルの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのシドホビル市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 シドホビルのグローバル主要プレイヤーには、Emcure Pharma、Mylan、Gilead Sciences、Tillomed Pharma、Marcan Pharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 シドホビル市場は、種類と用途によって区分されます。世界のシドホビル市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 溶液、粉末 【用途別セグメント】 サイトメガロウイルス網膜炎治療、イボ局所治療、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - シドホビル製品概要 - 種類別市場（溶液、粉末） - 用途別市場（サイトメガロウイルス網膜炎治療、イボ局所治療、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のシドホビル販売量予測2017-2028 - 世界のシドホビル売上予測2017-2028 - シドホビルの地域別販売量 - シドホビルの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別シドホビル販売量 - 主要メーカー別シドホビル売上 - 主要メーカー別シドホビル価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（溶液、粉末） - シドホビルの種類別販売量 - シドホビルの種類別売上 - シドホビルの種類別価格 ・用途別市場規模（サイトメガロウイルス網膜炎治療、イボ局所治療、その他） - シドホビルの用途別販売量 - シドホビルの用途別売上 - シドホビルの用途別価格 ・北米市場 - 北米のシドホビル市場規模（種類別、用途別） - 主要国別のシドホビル市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのシドホビル市場規模（種類別、用途別） - 主要国別のシドホビル市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のシドホビル市場規模（種類別、用途別） - 主要国別のシドホビル市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のシドホビル市場規模（種類別、用途別） - 主要国別のシドホビル市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのシドホビル市場規模（種類別、用途別） - 主要国別のシドホビル市場規模（トルコ、サウジアラビア） ・企業情報 Emcure Pharma、Mylan、Gilead Sciences、Tillomed Pharma、Marcan Pharma ・産業チェーン及び販売チャネル分析 - シドホビルの産業チェーン分析 - シドホビルの原材料 - シドホビルの生産プロセス - シドホビルの販売及びマーケティング - シドホビルの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - シドホビルの産業動向 - シドホビルのマーケットドライバー - シドホビルの課題 - シドホビルの阻害要因 ・主な調査結果 |
It is a topical or injectable antiviral medication primarily used as a treatment for cytomegalovirus (CMV) retinitis (an infection of the retina of the eye) in people with AIDS.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Cidofovir is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Cidofovir is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Cidofovir is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Cidofovir include Emcure Pharma, Mylan, Gilead Sciences, Tillomed Pharma and Marcan Pharma, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Cidofovir manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Cidofovir market. Further, it explains the major drivers and regional dynamics of the global Cidofovir market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Emcure Pharma
Mylan
Gilead Sciences
Tillomed Pharma
Marcan Pharma
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by dosage form and by application segments based on sales, price, and value for the period 2017-2028.
Cidofovir Segment by Dosage Form
Solution
Sowder
Cidofovir Segment by Application
Treatment of Cytomegalovirus Retinitis
Local Treatment of Warts
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Cidofovir market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Cidofovir, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Cidofovir, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Cidofovir, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cidofovir sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Cidofovir market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Cidofovir sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Emcure Pharma, Mylan, Gilead Sciences, Tillomed Pharma and Marcan Pharma, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Cidofovir in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Cidofovir manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by dosage form, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by dosage form, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by dosage form, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by dosage form, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by dosage form, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cidofovir sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Cidofovir Product Introduction
1.2 Market by Dosage Form
1.2.1 Global Cidofovir Market Size Growth Rate by Dosage Form, 2017 VS 2021 VS 2028
1.2.2 Solution
1.2.3 Sowder
1.3 Market by Application
1.3.1 Global Cidofovir Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Treatment of Cytomegalovirus Retinitis
1.3.3 Local Treatment of Warts
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cidofovir Sales Estimates and Forecasts 2017-2028
2.2 Global Cidofovir Revenue Estimates and Forecasts 2017-2028
2.3 Global Cidofovir Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cidofovir Sales by Region
2.4.1 Global Cidofovir Sales by Region (2017-2022)
2.4.2 Global Sales Cidofovir by Region (2023-2028)
2.5 Global Cidofovir Revenue by Region
2.5.1 Global Cidofovir Revenue by Region (2017-2022)
2.5.2 Global Cidofovir Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cidofovir Sales by Manufacturers
3.1.1 Global Top Cidofovir Manufacturers by Sales (2017-2022)
3.1.2 Global Cidofovir Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cidofovir in 2021
3.2 Global Cidofovir Revenue by Manufacturers
3.2.1 Global Cidofovir Revenue by Manufacturers (2017-2022)
3.2.2 Global Cidofovir Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cidofovir Revenue in 2021
3.3 Global Cidofovir Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cidofovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cidofovir Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Dosage Form
4.1 Global Cidofovir Sales by Dosage Form
4.1.1 Global Cidofovir Historical Sales by Dosage Form (2017-2022)
4.1.2 Global Cidofovir Forecasted Sales by Dosage Form (2023-2028)
4.1.3 Global Cidofovir Sales Market Share by Dosage Form (2017-2028)
4.2 Global Cidofovir Revenue by Dosage Form
4.2.1 Global Cidofovir Historical Revenue by Dosage Form (2017-2022)
4.2.2 Global Cidofovir Forecasted Revenue by Dosage Form (2023-2028)
4.2.3 Global Cidofovir Revenue Market Share by Dosage Form (2017-2028)
4.3 Global Cidofovir Price by Dosage Form
4.3.1 Global Cidofovir Price by Dosage Form (2017-2022)
4.3.2 Global Cidofovir Price Forecast by Dosage Form (2023-2028)
5 Market Size by Application
5.1 Global Cidofovir Sales by Application
5.1.1 Global Cidofovir Historical Sales by Application (2017-2022)
5.1.2 Global Cidofovir Forecasted Sales by Application (2023-2028)
5.1.3 Global Cidofovir Sales Market Share by Application (2017-2028)
5.2 Global Cidofovir Revenue by Application
5.2.1 Global Cidofovir Historical Revenue by Application (2017-2022)
5.2.2 Global Cidofovir Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cidofovir Revenue Market Share by Application (2017-2028)
5.3 Global Cidofovir Price by Application
5.3.1 Global Cidofovir Price by Application (2017-2022)
5.3.2 Global Cidofovir Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cidofovir Market Size by Dosage Form
6.1.1 North America Cidofovir Sales by Dosage Form (2017-2028)
6.1.2 North America Cidofovir Revenue by Dosage Form (2017-2028)
6.2 North America Cidofovir Market Size by Application
6.2.1 North America Cidofovir Sales by Application (2017-2028)
6.2.2 North America Cidofovir Revenue by Application (2017-2028)
6.3 North America Cidofovir Market Size by Country
6.3.1 North America Cidofovir Sales by Country (2017-2028)
6.3.2 North America Cidofovir Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Cidofovir Market Size by Dosage Form
7.1.1 Europe Cidofovir Sales by Dosage Form (2017-2028)
7.1.2 Europe Cidofovir Revenue by Dosage Form (2017-2028)
7.2 Europe Cidofovir Market Size by Application
7.2.1 Europe Cidofovir Sales by Application (2017-2028)
7.2.2 Europe Cidofovir Revenue by Application (2017-2028)
7.3 Europe Cidofovir Market Size by Country
7.3.1 Europe Cidofovir Sales by Country (2017-2028)
7.3.2 Europe Cidofovir Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cidofovir Market Size by Dosage Form
8.1.1 Asia Pacific Cidofovir Sales by Dosage Form (2017-2028)
8.1.2 Asia Pacific Cidofovir Revenue by Dosage Form (2017-2028)
8.2 Asia Pacific Cidofovir Market Size by Application
8.2.1 Asia Pacific Cidofovir Sales by Application (2017-2028)
8.2.2 Asia Pacific Cidofovir Revenue by Application (2017-2028)
8.3 Asia Pacific Cidofovir Market Size by Region
8.3.1 Asia Pacific Cidofovir Sales by Region (2017-2028)
8.3.2 Asia Pacific Cidofovir Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Cidofovir Market Size by Dosage Form
9.1.1 Latin America Cidofovir Sales by Dosage Form (2017-2028)
9.1.2 Latin America Cidofovir Revenue by Dosage Form (2017-2028)
9.2 Latin America Cidofovir Market Size by Application
9.2.1 Latin America Cidofovir Sales by Application (2017-2028)
9.2.2 Latin America Cidofovir Revenue by Application (2017-2028)
9.3 Latin America Cidofovir Market Size by Country
9.3.1 Latin America Cidofovir Sales by Country (2017-2028)
9.3.2 Latin America Cidofovir Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Cidofovir Market Size by Dosage Form
10.1.1 Middle East and Africa Cidofovir Sales by Dosage Form (2017-2028)
10.1.2 Middle East and Africa Cidofovir Revenue by Dosage Form (2017-2028)
10.2 Middle East and Africa Cidofovir Market Size by Application
10.2.1 Middle East and Africa Cidofovir Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cidofovir Revenue by Application (2017-2028)
10.3 Middle East and Africa Cidofovir Market Size by Country
10.3.1 Middle East and Africa Cidofovir Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cidofovir Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Emcure Pharma
11.1.1 Emcure Pharma Corporation Information
11.1.2 Emcure Pharma Overview
11.1.3 Emcure Pharma Cidofovir Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Emcure Pharma Cidofovir Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Emcure Pharma Recent Developments
11.2 Mylan
11.2.1 Mylan Corporation Information
11.2.2 Mylan Overview
11.2.3 Mylan Cidofovir Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Mylan Cidofovir Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Mylan Recent Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Corporation Information
11.3.2 Gilead Sciences Overview
11.3.3 Gilead Sciences Cidofovir Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Gilead Sciences Cidofovir Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Gilead Sciences Recent Developments
11.4 Tillomed Pharma
11.4.1 Tillomed Pharma Corporation Information
11.4.2 Tillomed Pharma Overview
11.4.3 Tillomed Pharma Cidofovir Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Tillomed Pharma Cidofovir Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Tillomed Pharma Recent Developments
11.5 Marcan Pharma
11.5.1 Marcan Pharma Corporation Information
11.5.2 Marcan Pharma Overview
11.5.3 Marcan Pharma Cidofovir Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Marcan Pharma Cidofovir Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Marcan Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cidofovir Industry Chain Analysis
12.2 Cidofovir Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cidofovir Production Mode & Process
12.4 Cidofovir Sales and Marketing
12.4.1 Cidofovir Sales Channels
12.4.2 Cidofovir Distributors
12.5 Cidofovir Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cidofovir Industry Trends
13.2 Cidofovir Market Drivers
13.3 Cidofovir Market Challenges
13.4 Cidofovir Market Restraints
14 Key Findings in The Global Cidofovir Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Cidofovir Market Size Growth Rate by Dosage Form, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Solution
Table 3. Major Manufacturers of Sowder
Table 4. Global Cidofovir Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Cidofovir Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Cidofovir Sales by Region (2017-2022) & (Vial)
Table 7. Global Cidofovir Sales Market Share by Region (2017-2022)
Table 8. Global Cidofovir Sales by Region (2023-2028) & (Vial)
Table 9. Global Cidofovir Sales Market Share by Region (2023-2028)
Table 10. Global Cidofovir Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Cidofovir Revenue Market Share by Region (2017-2022)
Table 12. Global Cidofovir Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Cidofovir Revenue Market Share by Region (2023-2028)
Table 14. Global Cidofovir Sales by Manufacturers (2017-2022) & (Vial)
Table 15. Global Cidofovir Sales Share by Manufacturers (2017-2022)
Table 16. Global Cidofovir Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Cidofovir Revenue Share by Manufacturers (2017-2022)
Table 18. Cidofovir Price by Manufacturers (2017-2022) &(US$/Vial)
Table 19. Global Cidofovir Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Cidofovir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cidofovir as of 2021)
Table 21. Cidofovir Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Cidofovir Product Offered
Table 23. Date of Manufacturers Enter into Cidofovir Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cidofovir Sales by Dosage Form (2017-2022) & (Vial)
Table 26. Global Cidofovir Sales by Dosage Form (2023-2028) & (Vial)
Table 27. Global Cidofovir Sales Share by Dosage Form (2017-2022)
Table 28. Global Cidofovir Sales Share by Dosage Form (2023-2028)
Table 29. Global Cidofovir Revenue by Dosage Form (2017-2022) & (US$ Million)
Table 30. Global Cidofovir Revenue by Dosage Form (2023-2028) & (US$ Million)
Table 31. Global Cidofovir Revenue Share by Dosage Form (2017-2022)
Table 32. Global Cidofovir Revenue Share by Dosage Form (2023-2028)
Table 33. Cidofovir Price by Dosage Form (2017-2022) & (US$/Vial)
Table 34. Global Cidofovir Price Forecast by Dosage Form (2023-2028) & (US$/Vial)
Table 35. Global Cidofovir Sales by Application (2017-2022) & (Vial)
Table 36. Global Cidofovir Sales by Application (2023-2028) & (Vial)
Table 37. Global Cidofovir Sales Share by Application (2017-2022)
Table 38. Global Cidofovir Sales Share by Application (2023-2028)
Table 39. Global Cidofovir Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Cidofovir Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Cidofovir Revenue Share by Application (2017-2022)
Table 42. Global Cidofovir Revenue Share by Application (2023-2028)
Table 43. Cidofovir Price by Application (2017-2022) & (US$/Vial)
Table 44. Global Cidofovir Price Forecast by Application (2023-2028) & (US$/Vial)
Table 45. North America Cidofovir Sales by Dosage Form (2017-2022) & (Vial)
Table 46. North America Cidofovir Sales by Dosage Form (2023-2028) & (Vial)
Table 47. North America Cidofovir Revenue by Dosage Form (2017-2022) & (US$ Million)
Table 48. North America Cidofovir Revenue by Dosage Form (2023-2028) & (US$ Million)
Table 49. North America Cidofovir Sales by Application (2017-2022) & (Vial)
Table 50. North America Cidofovir Sales by Application (2023-2028) & (Vial)
Table 51. North America Cidofovir Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Cidofovir Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Cidofovir Sales by Country (2017-2022) & (Vial)
Table 54. North America Cidofovir Sales by Country (2023-2028) & (Vial)
Table 55. North America Cidofovir Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Cidofovir Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Cidofovir Sales by Dosage Form (2017-2022) & (Vial)
Table 58. Europe Cidofovir Sales by Dosage Form (2023-2028) & (Vial)
Table 59. Europe Cidofovir Revenue by Dosage Form (2017-2022) & (US$ Million)
Table 60. Europe Cidofovir Revenue by Dosage Form (2023-2028) & (US$ Million)
Table 61. Europe Cidofovir Sales by Application (2017-2022) & (Vial)
Table 62. Europe Cidofovir Sales by Application (2023-2028) & (Vial)
Table 63. Europe Cidofovir Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Cidofovir Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Cidofovir Sales by Country (2017-2022) & (Vial)
Table 66. Europe Cidofovir Sales by Country (2023-2028) & (Vial)
Table 67. Europe Cidofovir Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Cidofovir Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Cidofovir Sales by Dosage Form (2017-2022) & (Vial)
Table 70. Asia Pacific Cidofovir Sales by Dosage Form (2023-2028) & (Vial)
Table 71. Asia Pacific Cidofovir Revenue by Dosage Form (2017-2022) & (US$ Million)
Table 72. Asia Pacific Cidofovir Revenue by Dosage Form (2023-2028) & (US$ Million)
Table 73. Asia Pacific Cidofovir Sales by Application (2017-2022) & (Vial)
Table 74. Asia Pacific Cidofovir Sales by Application (2023-2028) & (Vial)
Table 75. Asia Pacific Cidofovir Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Cidofovir Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Cidofovir Sales by Region (2017-2022) & (Vial)
Table 78. Asia Pacific Cidofovir Sales by Region (2023-2028) & (Vial)
Table 79. Asia Pacific Cidofovir Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Cidofovir Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Cidofovir Sales by Dosage Form (2017-2022) & (Vial)
Table 82. Latin America Cidofovir Sales by Dosage Form (2023-2028) & (Vial)
Table 83. Latin America Cidofovir Revenue by Dosage Form (2017-2022) & (US$ Million)
Table 84. Latin America Cidofovir Revenue by Dosage Form (2023-2028) & (US$ Million)
Table 85. Latin America Cidofovir Sales by Application (2017-2022) & (Vial)
Table 86. Latin America Cidofovir Sales by Application (2023-2028) & (Vial)
Table 87. Latin America Cidofovir Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Cidofovir Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Cidofovir Sales by Country (2017-2022) & (Vial)
Table 90. Latin America Cidofovir Sales by Country (2023-2028) & (Vial)
Table 91. Latin America Cidofovir Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Cidofovir Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Cidofovir Sales by Dosage Form (2017-2022) & (Vial)
Table 94. Middle East and Africa Cidofovir Sales by Dosage Form (2023-2028) & (Vial)
Table 95. Middle East and Africa Cidofovir Revenue by Dosage Form (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Cidofovir Revenue by Dosage Form (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Cidofovir Sales by Application (2017-2022) & (Vial)
Table 98. Middle East and Africa Cidofovir Sales by Application (2023-2028) & (Vial)
Table 99. Middle East and Africa Cidofovir Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Cidofovir Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Cidofovir Sales by Country (2017-2022) & (Vial)
Table 102. Middle East and Africa Cidofovir Sales by Country (2023-2028) & (Vial)
Table 103. Middle East and Africa Cidofovir Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Cidofovir Revenue by Country (2023-2028) & (US$ Million)
Table 105. Emcure Pharma Corporation Information
Table 106. Emcure Pharma Description and Major Businesses
Table 107. Emcure Pharma Cidofovir Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2017-2022)
Table 108. Emcure Pharma Cidofovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Emcure Pharma Recent Developments
Table 110. Mylan Corporation Information
Table 111. Mylan Description and Major Businesses
Table 112. Mylan Cidofovir Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2017-2022)
Table 113. Mylan Cidofovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Mylan Recent Developments
Table 115. Gilead Sciences Corporation Information
Table 116. Gilead Sciences Description and Major Businesses
Table 117. Gilead Sciences Cidofovir Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2017-2022)
Table 118. Gilead Sciences Cidofovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Gilead Sciences Recent Developments
Table 120. Tillomed Pharma Corporation Information
Table 121. Tillomed Pharma Description and Major Businesses
Table 122. Tillomed Pharma Cidofovir Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2017-2022)
Table 123. Tillomed Pharma Cidofovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Tillomed Pharma Recent Developments
Table 125. Marcan Pharma Corporation Information
Table 126. Marcan Pharma Description and Major Businesses
Table 127. Marcan Pharma Cidofovir Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2017-2022)
Table 128. Marcan Pharma Cidofovir Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Marcan Pharma Recent Developments
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Cidofovir Distributors List
Table 133. Cidofovir Customers List
Table 134. Cidofovir Market Trends
Table 135. Cidofovir Market Drivers
Table 136. Cidofovir Market Challenges
Table 137. Cidofovir Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Cidofovir Product Picture
Figure 2. Global Cidofovir Market Share by Dosage Form in 2021 & 2028
Figure 3. Solution Product Picture
Figure 4. Sowder Product Picture
Figure 5. Global Cidofovir Market Share by Application in 2021 & 2028
Figure 6. Treatment of Cytomegalovirus Retinitis
Figure 7. Local Treatment of Warts
Figure 8. Other
Figure 9. Cidofovir Report Years Considered
Figure 10. Global Cidofovir Sales 2017-2028 (Vial)
Figure 11. Global Cidofovir Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Cidofovir Revenue 2017-2028 (US$ Million)
Figure 13. Global Cidofovir Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Cidofovir Sales Market Share by Region (2017-2022)
Figure 15. Global Cidofovir Sales Market Share by Region (2023-2028)
Figure 16. North America Cidofovir Sales YoY (2017-2028) & (Vial)
Figure 17. North America Cidofovir Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Cidofovir Sales YoY (2017-2028) & (Vial)
Figure 19. Europe Cidofovir Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Cidofovir Sales YoY (2017-2028) & (Vial)
Figure 21. Asia-Pacific Cidofovir Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Cidofovir Sales YoY (2017-2028) & (Vial)
Figure 23. Latin America Cidofovir Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Cidofovir Sales YoY (2017-2028) & (Vial)
Figure 25. Middle East & Africa Cidofovir Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Cidofovir Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Cidofovir in the World: Market Share by Cidofovir Revenue in 2021
Figure 28. Global Cidofovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Cidofovir Sales Market Share by Dosage Form (2017-2028)
Figure 30. Global Cidofovir Revenue Market Share by Dosage Form (2017-2028)
Figure 31. Global Cidofovir Sales Market Share by Application (2017-2028)
Figure 32. Global Cidofovir Revenue Market Share by Application (2017-2028)
Figure 33. North America Cidofovir Sales Market Share by Dosage Form (2017-2028)
Figure 34. North America Cidofovir Revenue Market Share by Dosage Form (2017-2028)
Figure 35. North America Cidofovir Sales Market Share by Application (2017-2028)
Figure 36. North America Cidofovir Revenue Market Share by Application (2017-2028)
Figure 37. North America Cidofovir Sales Share by Country (2017-2028)
Figure 38. North America Cidofovir Revenue Share by Country (2017-2028)
Figure 39. United States Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Cidofovir Sales Market Share by Dosage Form (2017-2028)
Figure 42. Europe Cidofovir Revenue Market Share by Dosage Form (2017-2028)
Figure 43. Europe Cidofovir Sales Market Share by Application (2017-2028)
Figure 44. Europe Cidofovir Revenue Market Share by Application (2017-2028)
Figure 45. Europe Cidofovir Sales Share by Country (2017-2028)
Figure 46. Europe Cidofovir Revenue Share by Country (2017-2028)
Figure 47. Germany Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 48. France Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Cidofovir Sales Market Share by Dosage Form (2017-2028)
Figure 53. Asia Pacific Cidofovir Revenue Market Share by Dosage Form (2017-2028)
Figure 54. Asia Pacific Cidofovir Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Cidofovir Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Cidofovir Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Cidofovir Revenue Share by Region (2017-2028)
Figure 58. China Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 61. India Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Cidofovir Sales Market Share by Dosage Form (2017-2028)
Figure 68. Latin America Cidofovir Revenue Market Share by Dosage Form (2017-2028)
Figure 69. Latin America Cidofovir Sales Market Share by Application (2017-2028)
Figure 70. Latin America Cidofovir Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Cidofovir Sales Share by Country (2017-2028)
Figure 72. Latin America Cidofovir Revenue Share by Country (2017-2028)
Figure 73. Mexico Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 76. Colombia Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Cidofovir Sales Market Share by Dosage Form (2017-2028)
Figure 78. Middle East and Africa Cidofovir Revenue Market Share by Dosage Form (2017-2028)
Figure 79. Middle East and Africa Cidofovir Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Cidofovir Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Cidofovir Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Cidofovir Revenue Share by Country (2017-2028)
Figure 83. Turkey Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Cidofovir Revenue (2017-2028) & (US$ Million)
Figure 86. Cidofovir Value Chain
Figure 87. Cidofovir Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed